ASCO 2022

Area: Oncology

Location: Chicago, United States

Date: June 3 to June 7


Search in Scientific Content:
Date
Filters:
Results fr
5:010

Results from the phase 3 PARADIGM trial

Presenter: Yoshino Takayuki
Oncology
Pembrolizu
6:32

Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials?

Presenter: Richard D. Kim
Oncology

ESMO 2017

2017-09-08 - 2017-09-12
Madrid, Spain

ICML 2017

2017-06-14 - 2017-06-17
Lugano, Switzerland

ASCO 2017

2017-06-02 - 2017-06-06
Chicago, United States

SABCS 2016

2016-12-06 - 2016-12-10
San Antonio, United States

ESMO 2016

2016-10-07 - 2016-10-11
Copenhagen, Denmark

ASCO 2016

2016-06-03 - 2016-06-07
Chicago, United States

ELCC 2016

2016-04-13 - 2016-04-16
Geneva, Switzerland

ESMO ECCO 2015

2015-09-25 - 2015-09-29
Vienna, Austria

ASCO 2015

2015-05-29 - 2015-06-02
Chicago, United States